image credit: Adobe Stock

Eli Lilly/Boehringer’s Jardiance for children with type 2 diabetes accepted by FDA

March 9, 2023


Initially approved in 2014, Jardiance is a once-daily tablet used alongside diet and exercise to lower blood sugar in adults with type 2 diabetes. The drug, however, is not currently indicated for children.

Type 2 diabetes most often develops in people over the age of 45, but more children, teenagers and young adults are developing the condition, according to the Centers for Disease Control and Prevention.

Read More on PMLiVE